ethosuximide is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Mikart, Llc. The primary component is Ethosuximide.
| Product ID | 46672-641_9c6f1329-3590-7321-e053-2995a90a940c |
| NDC | 46672-641 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ethosuximide |
| Generic Name | Ethosuximide |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2003-12-22 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA040506 |
| Labeler Name | Mikart, LLC |
| Substance Name | ETHOSUXIMIDE |
| Active Ingredient Strength | 250 mg/5mL |
| Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2003-12-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA040506 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2003-12-22 |
| Ingredient | Strength |
|---|---|
| ETHOSUXIMIDE | 250 mg/5mL |
| SPL SET ID: | e7d4b2a4-2dae-4026-a381-9d534d36c6b3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0093-9660 | Ethosuximide | Ethosuximide |
| 0121-0670 | ETHOSUXIMIDE | ETHOSUXIMIDE |
| 23155-532 | ETHOSUXIMIDE | ETHOSUXIMIDE |
| 42806-711 | Ethosuximide | Ethosuximide |
| 46672-641 | ethosuximide | ethosuximide |
| 59762-2250 | Ethosuximide | Ethosuximide |
| 59762-2350 | Ethosuximide | Ethosuximide |
| 61748-024 | Ethosuximide | Ethosuximide |
| 61748-025 | Ethosuximide | Ethosuximide |
| 63629-8005 | Ethosuximide | Ethosuximide |
| 64380-878 | ETHOSUXIMIDE | ETHOSUXIMIDE |
| 68382-443 | ethosuximide | ethosuximide |
| 69387-108 | Ethosuximide | Ethosuximide |
| 69452-152 | Ethosuximide | Ethosuximide |
| 71335-1763 | ETHOSUXIMIDE | ETHOSUXIMIDE |
| 0071-0237 | Zarontin | Ethosuximide |
| 0071-2418 | Zarontin | Ethosuximide |